Certified Advisory Corp Pfizer Inc Transaction History

Certified Advisory Corp

$778 Million
Q2 2024

A detailed history of Certified Advisory Corp transactions in Pfizer Inc stock. As of the latest transaction made, Certified Advisory Corp holds 82,840 shares of PFE stock, worth $2.21 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

82,840

Previous 81,527 1.61%

Holding current value

$2.21 Million

Previous $2.26 Million 2.43%

% of portfolio

0.3%

Previous 0.32%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $33,166 - $38,864	1,313 Added 1.61%	82,840 $2.32 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $431,172 - $495,123	16,654 Added 25.67%	81,527 $2.26 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $23,177 - $30,104	887 Added 1.39%	64,873 $1.87 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $36,165 - $42,273	1,127 Added 1.79%	63,986 $2.12 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $85,459 - $98,875	-2,366 Reduced 3.63%	62,859 $2.31 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $20,482 - $26,665	520 Added 0.8%	65,225 $2.66 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $12,191 - $15,914	-292 Reduced 0.45%	64,705 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $5,032 - $6,143	115 Added 0.18%	64,997 $2.85 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $15,866 - $18,812	341 Added 0.53%	64,882 $3.4 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $46,893 - $58,107	-1,025 Reduced 1.56%	64,541 $3.34 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $9,090 - $13,475	220 Added 0.34%	65,566 $3.87 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $45,883 - $58,940	1,169 Added 1.82%	65,346 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $195,817 - $221,828	5,453 Added 9.29%	64,177 $2.51 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $120,430 - $135,820	3,596 Added 6.52%	58,724 $2.13 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $165,810 - $201,152	5,505 Added 11.09%	55,128 $1.8 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $131,446 - $187,809	4,863 Added 10.86%	49,623 $1.62 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $401,426 - $455,567	12,194 Added 37.44%	44,760 $1.75 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $339,130 - $439,752	10,438 Added 47.17%	32,566 $1.17 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $3,550 - $3,985	-96 Reduced 0.43%	22,128 $959,000
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $80,025 - $87,920	2,134 Added 10.62%	22,224 $943,000
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $6,039 - $6,886	157 Added 0.79%	20,090 $877,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $11,444 - $13,880	-332 Reduced 1.64%	19,933 $879,000
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $11,938 - $12,727	362 Added 1.82%	20,265 $735,000
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $427,306 - $495,734	13,391 Added 205.64%	19,903 $705,000
Q4 2017 Feb 22, 2018	BUY	$33.26 - $35.29 $216,589 - $229,808	6,512	6,512 $235,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Pfizer Inc Transaction History